Concepedia

James A. Cooper

JA

Statistics

Publications

31

Citations

2K

H-Index

16

Active since

1971

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Research Triangle Park Foundation

University of Sheffield

Royal Hallamshire Hospital

Minnesota Department of Natural Resources

James A. Cooper is an author at GlaxoSmithKline (United Kingdom) specializing in life sciences, medicine, and parkinson disease.

Publications per year

1971–2024

31

Publications

31

COGNITIVE IMPAIRMENT IN EARLY, UNTREATED PARKINSON'S DISEASE AND ITS RELATIONSHIP TO MOTOR DISABILITY

James A. Cooper, H. J. Sagar, Nigel Jordan et al. · Brain · 1991 · 630 citations

Medicine, Neurology, Neuroscience +17

Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease

Gordon Wilcock, Clive Ballard, James A. Cooper et al. · The Journal of Clinical Psychiatry · 2008 · 248 citations

Medicine, Pharmacotherapy, Psychiatry +17

Slowed central processing in simple and go/no-go reaction time tasks in Parkinson's disease

James A. Cooper, H. J. Sagar, P Tidswell et al. · Brain · 1994 · 161 citations

Social Sciences, Neurology, Neuroscience +17

Influences of seasonal flooding on macroinvertebrate abundance in wetland habitats

Hilary A. Neckles, Henry R. Murkin, James A. Cooper · Freshwater Biology · 1990 · 139 citations

Life Sciences, Ecology, Community Ecology +16

Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson’s disease

К. Ray Chaudhuri, Pablo Martínez‐Martín, Katie Rolfe et al. · European Journal of Neurology · 2011 · 103 citations

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 31